Sophie Bannister and Levi-April Whalley told border police at Birmingham Airport they had gone on a shopping trip to New York ...

Neurona will kick start a Phase III trial in H2 2025 investigating NRTX-1001 in patients with a type of drug-resistant ...

Richardson, has published promising findings from the past seven years of research into a new approach for the treatment of ...

A Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic pontine glioma (DIPG) is safe, reported Weill Cornell Medicine and ...

Names like idarucizumab, levetiracetam and ustekinumab may look like words from Greek or Norse mythology, but they're chosen ...

Leading artificial intelligence (AI) driven drug discovery and bioinformatics, Dr. Sita Sirisha Madugula is making ...

Older adults and those with a worse thyroid eye disease clinical activity score at baseline were less likely to respond to ...

TMS, and gene therapy offer hope for alcohol addiction recovery. Discover how these options could change addiction treatment.

A secluded corner surrounded by litter and makeshift structures on the outskirts of South Africa’s capital is home to ...

The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is still trading at three-year highs, despite current market volatility, in response to breakthrough innovations and increased deals involving biotech ...

Researchers suggest results could reignite interest in DLK inhibition as a treatment strategy for neurodegenerative diseases.

Our meeting with the FDA yesterday was very productive, and we remain on track for an NDA filing of CTx-1301 in mid-2025. We truly appreciate the FDA personnel who have been involved with the ...